Dashboard
Manage Tickers

LPTX LEAP THERAPEUTICS, INC.

Nasdaq leaptx.com


$ 0.54 $ 0.00 (0 %)    

Tuesday, 21-Oct-2025 07:12:46 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.91 $ 0.00 (0 %)
DIA $ 467.33 $ 0.00 (0 %)
SPY $ 671.76 $ 0.00 (0 %)
TLT $ 91.66 $ 0.00 (0 %)
GLD $ 388.53 $ 0.00 (0 %)
$ 0.5226
$ 0.57
$ 0.50 x 100
$ 0.54 x 1,789
-- - --
$ 0.22 - $ 4.79
1,886,605
na
21.66M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-26-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-12-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-18-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-24-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-11-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-13-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-12-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-16-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 04-01-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-11-2018 03-31-2018 10-Q
31 02-23-2018 12-31-2017 10-K
32 11-13-2017 09-30-2017 10-Q
33 08-11-2017 06-30-2017 10-Q
34 05-12-2017 03-31-2017 10-Q
35 03-31-2017 12-31-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

leap-therapeutics-reports-final-results-from-part-b-of-defiance-study-phase-2-study-of-sirexatamab-in-mss-crc-patients-who-have-received-one-prior-systemic-therapy-for-advanced-disease
Leap Therapeutics Reports Final Results Fr...
10/20/2025 11:07:46

Sirexatamab demonstrated statistically significant improvement in PFS and OS in DKK1-high populationIncreasing DKK1 levels furt...

leap-therapeutics-closes-private-placement-led-by-winklevoss-capital-raising-5888m-in-cash-to-initiate-digital-asset-treasury-strategy
Leap Therapeutics Closes Private Placement...
10/09/2025 11:16:29

why-is-leap-therapeutics-down-9-in-pre-market-trading
Why Is Leap Therapeutics Down 9% In Pre-Ma...
10/07/2025 08:55:11

Leap Therapeutics is trading lower in pre-market following a $58.9 million private placement led by Winklevoss Capital.

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/06/2025 17:07:04

leap-therapeutics-secures-589m-pipe-led-by-winklevoss-capital-for-9585m-shares-and-warrants-to-buy-719m-shares
Leap Therapeutics Secures $58.9M PIPE Led ...
10/06/2025 13:05:00

Leap Therapeutics (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/03/2025 17:06:08

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 12:09:25

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
09/12/2025 21:06:30

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/26/2025 12:09:56

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/14/2025 17:06:18

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/14/2025 12:08:55

leap-therapeutics-q2-eps-040-misses-029-estimate
Leap Therapeutics Q2 EPS $(0.40) Misses $(...
08/14/2025 11:06:06

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 12:08:30

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 21:06:19

leap-therapeutics-has-initiated-the-process-to-explore-strategic-alternatives
Leap Therapeutics Has Initiated The Proces...
06/23/2025 11:08:30

leap-therapeutics-reports-updated-results-from-part-b-of-defiance-phase-2-study-of-sirexatamab-in-combination-with-bevacizumab-and-chemotherapy-vs-bevacizumab-and-chemotherapy-for-advanced-microsatellite-stable-colorectal-cancer
Leap Therapeutics Reports Updated Results ...
06/23/2025 11:07:33

Updated data from DeFianCe study continue to demonstrate statistically significant improvements in PFS among the DKK1-high, VEG...

leap-therapeutics-q1-eps-037-beats-038-estimate
Leap Therapeutics Q1 EPS $(0.37) Beats $(0...
05/13/2025 11:14:25

Leap Therapeutics (NASDAQ:LPTX) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/27/2025 12:05:52

hc-wainwright--co-reiterates-neutral-on-leap-therapeuticsto-neutral
HC Wainwright & Co. Reiterates Neutral on ...
03/27/2025 10:33:21

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Leap Therapeutics (NASDAQ:LPTX) from Neutral to Neutral.

penny-stock-leap-therapeutics-unveils-positive-data-from-experimental-combo-therapy-for-colorectal-cancer
Penny Stock Leap Therapeutics Unveils Posi...
03/26/2025 17:29:11

Leap Therapeutics' Phase 2 trial data show sirexatamab boosts response rates and survival in MSS colorectal cancer, with on...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION